# Boundless Bio, Inc. (BOLD): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Boundless Bio, Inc. (BOLD) is 34/100, ranked against 24,000+ stocks in 35 markets (Quality 24, Value 35, Momentum 65, each scored against its sector).

- StockRank: 34/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 24, Value 35, Momentum 65: each a 0-100 percentile within Healthcare.
- Position: #17,504 overall, #1,524 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 2.41 USD on 26 Oct 2026.
- Insider filings, last 180 days: 5%+ holders bought USD 1.9M; 5%+ holders sold USD 94K.

Source: https://moatmap.ai/stock/BOLD
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker